Role of Clinical Criteria and Oxygen Saturation Monitoring in Diagnosis of Childhood Pneumonia in Children Aged 2 to 59 Months
Background Current WHO algorithm has retained the signs and symptoms used in the older version for classifying severity of childhood pneumonia. Objective To study the role of clinical features (including that of current WHO criteria), and oxygen saturation (SpO2) in the diagnosis of childhood pneumo...
Gespeichert in:
Veröffentlicht in: | Indian pediatrics 2021-11, Vol.58 (11), p.1024-1029 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Current WHO algorithm has retained the signs and symptoms used in the older version for classifying severity of childhood pneumonia.
Objective
To study the role of clinical features (including that of current WHO criteria), and oxygen saturation (SpO2) in the diagnosis of childhood pneumonia.
Study design
Multicenter prospective cohort study.
Participants
Children, 2 to 59 months of age, suffering from acute respiratory infection (ARI).
Outcome measures
Sensitivity, specificity, and likelihood ratios were calculated for clinical features, and SpO2.
Results
Of a total 7026 children with ARI enrolled, 13.4% had pneumonia (37% of them had severe pneumonia), according to WHO criteria. Based on any abnormality on chest x ray (CXR), 46% had pneumonia. The sensitivity and specificity of the existing WHO criteria for diagnosis of pneumonia was 56.5% and 66.2%, respectively, when compared against abnormalities in CXR. Cough and fever, each had sensitivity of >80%. Audible wheeze and breathing difficulty, each had a specificity of >80%. Sensitivity and specificity of tachypnoea were 58.7% and 63.3%, respectively. None of the clinical features alone had a sensitivity and specificity of >80%. Addition of SpO2 of |
---|---|
ISSN: | 0019-6061 0974-7559 |
DOI: | 10.1007/s13312-021-2367-3 |